Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELI-TBI: Sodium Lactate in Traumatic Brain Injury
NCT02776488Phase 2Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Sep 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lactated ringer's solution in traumatic brain injury (TBI), sponsored by University of California, Los Angeles. Primary endpoint: Mortality within 30 days. Planned start Sep 2020; status: withdrawn.
02
Drugs
lactated ringer's solution
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02776488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02776488.